s

Since January 22nd, 2026, Accellix is part of bioMérieux, a world leader in the field of in vitro diagnostics.

Learn more about this strategic acquisition.

WATCH PRESENTATION

Overcoming Challenges Faced with Traditional Flow Cytometry in Cell Therapy Manufacturing with the Accellix Automated Flow Cytometer

Watch Now »

To Access Video, Please Complete this Form:

    Interest*